Occupational toluene exposure induces cytochrome P450 2E1 mRNA expression in peripheral lymphocytes.
Solvents are complex chemical mixtures containing many different hydrocarbon types, such as alkanes, alcohols, ketones, aldehydes, esters, ethers, and small aromatic molecules, that evaporate and become incorporated into environmental air as volatile organic compounds (VOCs). Although the percentage of each chemical in solvent formulations varies among commercial brands, toluene is ubiquitously the most abundant ingredient (Mercado-Calderon 1997). Products used in many industrial workshops and in the home contain potentially hazardous solvents. Therefore, people working in such industries or at home risk continuous exposure to VOCs released from solvents.
Toluene is a systemic toxicant that affects liver, kidney, and the central nervous system [Agency for Toxic Substances and Disease Registry (ATSDR) 2000], the last being considered the main target organ (Byrne et al. 1991). Toluene biotransformation takes place in the liver by the cytochrome P450 2El (CYP2E1) isoform, producing hippuric acid, which is excreted in urine (Nakajima and Wang 1994). Toluene also up-regulates its own metabolism by inducing CYP2E1 activity in rat liver and peripheral lymphocytes (Gonzalez-Jasso et al. 2003). CYP2E1 induction is relevant because this enzyme activates man)' xenobiotics to become ultimate toxicants (Guengerich and Shimada 1991). In fact, CYP2E1 induction is the first step leading to the development of certain chemically mediated cancers (Lieber 1997). Consequently, exposure to toluene in an occupational setting could represent an increased risk of toxicity. CYP2E1 polymorphisms may also modulate this condition, although the extent to which 5'-flanking region RsaI/PstI polymorphisms alter induction is not clear (Wormhoudt et al. 1999).
Because of the significant health risks associated with high levels of solvent exposure, routine monitoring of exposed subjects and their work environment is necessary to ensure good occupational health and safety conditions. It is thus advisable to perform studies at multiple levels to elucidate the mechanisms involved in mediating occupational chemical exposure effects, and to search for earlier and more sensitive biomarkers that will improve occupational safety (Mutti 1999). Accordingly, several studies have been reported with the aim of assessing environmental and health conditions of VOC-exposed workers (Apostoli et al. 1982; Wallen 1986); CYP2E1 phenotype determination in such populations may provide additional information.
Chlorzoxazone (CHZ) is a centrally acting muscle relaxant drug that has been used extensively as a selective probe for CYP2E1 phenotyping; this isoform is the main enzyme involved in its 6-hydroxylation (6OH-CHZ) in humans (Lucas et al. 1999). However, because CHZ clinical prescription is no longer available in Europe and is under revision in the United States (Lucas et al. 2001), it should no longer be used as a routine monitoring probe (Tanaka et al. 2003). Therefore, alternative methods to assay CYP2E1 phenotype in vivo are being investigated. Raucy et al. (1997) reported a relationship between CYP2E1 activity in peripheral blood lymphocyte microsomes and plasma CHZ metabolic ratio (6OH-CHZ/CHZ quotient; CYP2E1 metabolism indicator) in alcoholic subjects. This association suggests that peripheral lymphocytes and liver are regulated similarly and could be advantageous for monitoring purposes (Gonzalez-Jasso et al. 2003). Little information, however, is available about the effects of environmental VOCs on CYP2E1 regulation in human peripheral lymphocytes. Consequently, we investigated the association of toluene exposure with both CYP2E1 mRNA content in peripheral lymphocytes and CHZ 6-hydroxylation in occupationally exposed subjects. We further assessed the contribution of the 5'-flanking region RsaI/PstI polymorphism in measured lymphocyte CYP2E1 mRNA content and CHZ 6-hydroxylation.
Materials and Methods
Study design. A cross-sectional study was performed with print industry workers in Mexico City. The study population consisted of 103 unrelated male print workers employed as flat or rotary printing press operators (24%), operator assistants (33%), ink handlers (22%), machine maintenance personnel (mechanics and electricians) (13%), or supervisors (8%). Workers were exposed to a commercial nonbenzene-containing organic solvent, composed of a complex mixture of VOCs, of which toluene and xylene were the main constituents. Inclusion criteria for participants were 2-fold: a) only clinically healthy males with normal hepatic function test values were included, and b) only those not taking drugs that alter CYP2E1 activity (e.g., acetaminophen, isoniazid, disulfiram, chlormethiazole, or chloroquine) were included (Frye and Branch 2002; Park et al. 1993; Simi and Ingelman-Sundberg 1999).
Workers were contacted through the National Coordination of Health at the Workplace (Instituto Mexicano del Seguro Social) and received a thorough explanation of the aims and procedures of this investigation; participants signed an informed consent form (response ratio, 85%). Subjects were directly interviewed by trained personnel in order to record clinical, occupational, and sociodemographic characteristics, tobacco and alcohol consumption, and use of personal protection equipment. In addition, the body mass index (BMI) was calculated for each subject as the quotient of body weight divided by the square of the height (Brown 1995). Subjects were instructed to avoid smoking and alcohol consumption for 5 days before the sample collection (Plee-Gautier et al. 2001). The CINVESTAV-IPN Ethical Committee approved this investigation protocol.
Quantitation of toluene levels in the environment. Personal monitors measured toluene environmental levels in the indoor air of working areas. Each worker wore a Radiello passive diffusion monitor (code 130; Fondazione Salvatore Maugeri, Padua, Italy) placed within the respiratory area, for an 8-hr work shift. To extract absorbed solvent molecules, 2 mL carbon disulfide was applied to the monitors, and they were placed on the laboratory bench for 30 min and given an occasional shake. Extracts were analyzed by gas chromatography/mass spectrometry, using a Finnigan chromatograph (San Jose, CA, USA) equipped with a PONA capillary column (50 m x 0.25 mm inner diameter x 0.25 [micro]m film thickness; stationary phase, 5% phenylmethyl silicone) and a flame ionization detector (FID). Run conditions were as follows: initial temperature was 40[degrees]C; then the temperature was increased at an initial ramp of 10[degrees]C/min to 150[degrees]C and a second ramp of 15[degrees]C/min to 180[degrees]C (2 min). The injector (splitless mode) temperature was 200[degrees]C, the FID temperature was 250[degrees]C, and the carrier gas (helium 99.998%; Praxair, Mexico City, Mexico) was sustained at a constant flow rate of 35 mL/min. We identified and quantified the chemicals present in the extract samples by comparison with standards (ChemService, West Chester, PA, USA) (Cocheo 1983).
Biologic sampling. Blood samples were collected from each subject's radial vein and placed in tubes with or without EDTA for lymphocyte isolation and CHZ metabolism evaluation or liver function tests (serum), respectively. Urine samples were obtained at the beginning and end of an 8-hr work shift and used to measure hippuric acid levels. Liver function was assessed in serum by measuring alanine aminotransferase, aspartate aminotransferase, and gamma-glutamyl transferase activities (Bergmeyer and Horder 1980). Creatinine was measured in urine by the Jaffe reaction method (Bartels and Bohmer 1972).
Quantitation of urinary hippuric acid. We measured urinary hippuric acid according to the recommendations of the National Institute for Occupational Safety and Health (NIOSH 1994). Briefly, we acidified a 1-mL urine sample by adding 40 [micro]L hydrochloric acid, saturated the solution with 0.3 g sodium chloride, and then extracted hippuric acid by combining the solution with 4 mL ethyl acetate and shaking the mixture for 5 min. After centrifugation at 3,000 rpm for 10 min, the organic layer was evaporated under a nitrogen stream until dry and then redissolved in 1 mL distilled water. Recovery percentage was calculated by addition of a hippuric acid standard to urine samples; this control calculation with the standard revealed a 95% mean recovery rate.
Urine extracts were analyzed by high-performance liquid chromatography (HPLC) with a Perkin Elmer 235C chromatograph (PerkinElmer, Norwalk, CT) equipped with a diode array detector and a 50 [micro]L loop. Samples were separated in a 250 mm x 5 mm Spherisorb Ps phaseb column packed with 5 [micro]m [C.sub.18] reversed phase (Phase Separation Inc., Norwalk, CT, USA). The mobile phase was a mixture of acetonitrile and 0.2% glacial acetic acid in water (10:90 vol/vol) and was maintained at a flow of 1 mL/min. The wavelength setting was 254 nm.
Quantitation of CHZ and 60H-CHZ in plasma. After a 12-hr fast, volunteers ingested a CHZ tablet (500 mg; Barr Laboratories, Pomona, NY, USA) and gave blood samples 2 hr later. Plasma was separated by centrifugation at 1,500 rpm for 10 min. CHZ and 6OH-CHZ were measured according to the methods described by Lucas et al. (1993). Plasma samples (0.5 mL) were digested overnight at 37[degrees]C with 20 [micro]L Helix pomatia juice (132,000 units [beta]-glucuronidase/mL; Sigma Chemical Co., Mexico City, Mexico) to hydrolyze 6OH-CHZ conjugates. Proteins were subsequently precipitated by addition of 0.6 N perchloric acid (4 mL). After centrifugation at 3,000 rpm for 10 min, CHZ and 6OH-CHZ were extracted from the supernatant twice with ethyl acetate (4 mL) by shaking for 90 min and centrifugation at 3,000 rpm at 4[degrees]C for 10 min. The organic layer was isolated, allowed to evaporate under a nitrogen stream until dry, and then resuspended in 0.5 mL of mobile phase. Recovery percentage was calculated in bovine serum samples with added CHZ and 6OH-CHZ standards that were analyzed simultaneously with the study samples.
CHZ and 6OH-CHZ levels were measured by HPLC using a Lambda-Max model 481 chromatograph (Waters Co., Milford, MA, USA) equipped with an ultraviolet detector and a 20 [micro]L loop, and compound separation was carried out using a 250 mm x 5 mm Spherisorb Ps phaseb column, packed with 5 [micro]m [C.sub.18] reversed phase (Phase Separation Inc.). The mobile phase contained acetonitrile, 0.5% glacial acetic acid, and water (30:70 vol/vol) and was maintained at a flow rate of 1 mL/min. The wavelength setting was 287 nm. This procedure achieved a 65% mean recovery rate for CHZ and 6OH-CHZ, and the CHZ metabolic ratios reported were calculated.
Evaluation of peripheral lymphocyte CYP2E1 mRNA content. Isolation of total RNA. Lymphocytes were separated from 7 mL of whole blood as described by Boyum (1968). Briefly, blood diluted 1:1 with saline solution was layered over 5 mL Lymphoprep (Nycomed Pharma AS, Oslo, Norway). After centrifugation at 1,600 rpm for 25 min at 25[degrees]C, we transferred the cell interface to a new tube, washed it twice with saline solution, and then centrifuged it at 1,200 rpm for 10 min at room temperature. Finally, the supernatant was discharged, and cells were prepared for RNA extraction treatment. Total RNA was extracted using TRIzol reagent (Gibco BRL, Life Technologies, Rockville, MD, USA) following the manufacturer's instructions. Extracted RNA samples were suspended in diethylpyrocarbonate-treated water (20 [micro]L). Total RNA was spectrophotometrically quantified, and its integrity was visualized by electrophoresis on 1.5% agarose gels stained with ethidium bromide.
Preparation of standard RNA. A set of primers was designed based on the human CYP2E1 cDNA sequence (GenBank accession number NM000773; National Center for Biotechnology Information, Bethesda, MD, USA) to amplify a 443-bp fragment of the CYP2E1 cDNA. The forward primer CYP2E 1F (5'-ACAGGGACAGGGGAATCAT-3') is located at the junction of exons 2 and 3, and the reverse primer CYP2E1R (5'-TGGGGTCCAGAGATTGATG-3') is located within exon 5. Using modified versions of these primers, we constructed a standard RNA (recRNA) of the same length and sequence as endogenous CYP2E1 mRNA, except for a 71-bp deletion in the middle of the sequence. Construction of this competitor was accomplished in two steps. In the first step, primers T7CYP2E1 (5'-TAATACGACTCACTATAGGACAGGGA-CAGGGGAATCAT-3') and recRNA (5'-TGGGGTCCAGAGATTGATGCAGGCAAGTAGTGTAGAAAG-3') were used to amplify a cDNA from human peripheral blood lymphocytes. Primer T7CYP2E1 contains the T7 promoter sequence at the 5'-end of primer CYP2E1F (underlined sequence), and primer recRNA corresponds to CYP2E1R with the exception of a mismatching stretch of 20 bp located at the 3'-end (underlined sequence). In the human CYP2E1 cDNA sequence, the 20-bp stretch maps 98 bp upstream from the CYP2E1R sequence, but in the recRNA primer both sequences were linked together to allow the further generation of the deleted polymerase chain reaction (PCR) fragment (Figure 1). The PCR product was purified with a column (Freeze 'N Squeeze DNA gel extraction spin column; BioRad Laboratories, Hercules, CA, USA). In the second step, recRNA derived from the PCR fragment containing the T7 promoter sequence was prepared by in vitro transcription with a T7 Transcription Kit (Roche Diagnostics GmbH, Mannheim, Germany), according to the manufacturer's instructions. The recRNA was subsequently treated with RNase-free DNase (Boehringer Mannheim, Mannhein, Germany) to remove DNA template, recRNA was quantified by measuring its absorbance at 260 nm.
[FIGURE 1 OMITTED]
Quantitative reverse transcriptase (RT)-PCR. Endogenous RNA and recRNA were co-reverse transcribed and amplified simultaneously. Reverse transcription reactions were performed in a final volume of 21 [micro]L containing 16 mM Tris-HCl (pH 8.4), 40 mM KCl, 0.4 mM dithiothreitol, 4 mM Mg[Cl.sub.2], 0.4 mM of each deoxynucleotide triphosphate, 0.5 [micro]g oligo(dT), 40 U recombinant ribonuclease inhibitor RNaseOUT (Invitrogen, Carlsbad, CA, USA), and variable amounts of cellular RNA and recRNA. Sample solutions were incubated at 65[degrees]C for 10 min, 42[degrees]C for 50 min, and 70[degrees]C for 15 min. Fifty units of Superscript II reverse transcriptase was then added to each sample, and the samples were incubated at 42[degrees]C for 50 min and 70[degrees]C for 15 min. The reaction was terminated by rapid chilling on ice and by adding 4 U Escherichia coli RNase H (Invitrogen). The cDNA samples were amplified with primers CYP2E1F and CYP2E1R in 25 [micro]L PCR buffer (100 ng of each primer, 1 U Taq polymerase, 200 mM Tris-HCl, pH 8.4, 500 mM KCl, 50 mM Mg[Cl.sub.2], and 0.2 mM dNTP mixture), using the following PCR conditions: an initial denaturing step at 95[degrees]C for 5 min followed by 37 cycles of amplification that consisted of a denaturing step at 95[degrees]C for 30 sec, an annealing step at 56[degrees]C for 30 sec, and an extension step at 72[degrees]C for 30 sec. The reaction was terminated with a final extension step at 72[degrees]C for 5 min. All reactions were carried out in a Thermocycler GeneAmp PCR System 2400 (Applied Biosystems, Foster City, CA, USA). The RT-PCR reaction yielded a 453 bp fragment from endogenous RNA and a 382 bp fragment from recRNA (Figure 2). The CYP2E1 mRNA ratio was obtained by dividing the intensity of the endogenous mRNA band by the intensity of recRNA band.
[FIGURE 2 OMITTED]
DNA sequencing. To verify the authenticity of cellular and standard PCR products, they were sequenced in an ABI PRISM 310 Genetic Analyzer using the ABI PRISM Big Dye DNA sequencing kit (Applied Biosystems).
CYP2E1 genotype. CYP2E1 genotype was assessed by restriction fragment length polymorphism analysis for the 5'-flanking region RsaI/PstI polymorphic sites (Figure 1), according to the method described by Hayashi et al. (1991).
Statistical analysis. Differences between initial and final hippuric acid concentrations were compared by Student's t-test. Log transformations improved normality for CYP2E1 activity and urinary hippuric acid concentrations. Simple and multiple linear regression analyses were carried out to determine whether there were any associations between toluene exposure and CYP2E1 phenotype (enzymatic activity or mRNA content). These relationships were stratified by RsaI/PstI polymorphic site alleles. Multiple regression models were adjusted by age, BMI (classified as normal, overweight, and obesity), current drug consumption (categorized as yes or no), smoking habit (smokers or nonsmokers), and alcohol consumption (ranked as never, < 1 serving/ week; seldom, 1 to 2 servings/week; frequent, > 2 servings/week). All statistical analyses were conducted using the STATA 8.0 software package (Stata Corporation, College Station, TX, USA).
Demographic and health characteristics of the study population. Among 103 male workers, 6 subjects were excluded because of abnormal liver function. The remaining 97 subjects had a mean age of 34.2 years (range, 18-63 years) and a mean employment time of 3.5 years (range, 1-9 years). The BMI data indicated that 70% of the subjects exhibited some degree of obesity. In addition, 55% of the study subjects were smokers, 92% of them declared some degree of alcohol consumption, and 10% considered themselves to be frequent drinkers. Table 1 summarizes the anthropometric characteristics and habits of the study population.
Environmental toluene and urinary hippuric acid levels. Table 2 summarizes the indoor air toluene concentrations to which the workers were exposed in the print workshop and the levels of toluene exposure biologic markers. Air toluene concentrations monitored individually for a work shift had a geometric mean (GM) of 52.80 ppm (range, 10-760 ppm). Thus, 54% of the subjects studied were exposed to toluene levels that exceeded the 50 ppm maximal permissible exposure level (MPEL) (NOM-010-STPS- 1999 2000).
The GM of the urinary hippuric acid at the beginning and the end of a work shift were 0.027 and 0.041 g/g creatinine, respectively. Both values were below the maximal biologic permissible level (MBPL) of 2.5 g/g creatinine (NOM-047-SSA1-1993 1996). However, these data represent a 48% increase in urinary hippuric acid GM from the beginning to the end of the shift (p < 0.05) (Figure 3). This increase is consistent with the occurrence of active toluene absorption and biotransformation during the work shift.
[FIGURE 3 OMITTED]
CY2E1 mRNA associations with toluene, hippuric acid, and the toluene exposure ratio. In the present study, we assessed toluene exposure in two steps. First, toluene levels in work area air and hippuric acid levels in urine were measured for each subject, and these data were individually associated with the subject's CYP2E1 mRNA data. These comparisons yielded statistically significant but opposite correlations. That is, environmental toluene correlated positively with CYP2E1 mRNA levels ([r.sup.2] = 0.062, [beta] = 0.011, p = 0.029; n = 76), whereas urinary hippuric acid levels correlated negatively with CYP2E1 mRNA levels ([r.sup.2] = 0.065, [beta] = -4.120, p = 0.027; n = 71). This dissociation may be due to the capacity of toluene to induce CYP2E1 mRNA expression, whereas hippuric acid reflects toluene disposition. Therefore, we conducted further analysis with the toluene exposure ratio, which was calculated as the quotient of each individual's environmental toluene concentration exposure divided by his measured urine hippuric acid concentration. CYP2E1 mRNA level and the toluene exposure ratio showed a statistically significant relationship (p < 0.05) (Figure 4). Using this ratio enabled each subject's exposure to be more accurately described, bearing in mind the variability between internal and external conditions among workers and allowing us to normalize the individual differences observed in toluene metabolism. Such inter-individual differences are likely to result from several factors: a) differing toluene exposures that lead to different hippuric acid production; b) a competitive inhibition of toluene metabolism by other VOCs, which was greater in workers exposed to high toluene concentrations; c) differing metabolic statuses, depending upon individual genetic characteristics and the extent of CYP2E1 induction; and d) possible development of a tolerance to toluene, as has been described for other CYP2E1 substrates (Shayiq et al. 1999). The GM for the toluene exposure ratio was 0.122, ranging between 0.007 and 3.366 (Table 2).
[FIGURE 4 OMITTED]
CYP2E1 phenotype and genotype in the study population. CHZ biotransformation is related to CYP2E1 activity (Lucas et al. 1999), which is induced by toluene (Uaki et al. 1995). However, CHZ metabolism can be competitively inhibited by other contaminants in an occupational setting (Lucas et al. 1999); such effects will be reflected in the CHZ metabolic ratio. The GM of the CHZ metabolic ratio was 0.33 (0-9.3); however, 40% of the study population values were < 0.3. On the other hand, blood peripheral lymphocyte CYP2E1 mRNA content was 1.07 with a range of 0.03-3.08 (Table 2).
Genotype frequencies for the RsaI/PstI polymorphisms were reported previously (Mendoza-Cantu et al. 2003). Briefly, 60 native homozygous (c1/c1), 34 heterozygous (c1/c2), and 3 homozygous (c2/c2) subjects were found. These genotype frequencies are in accordance with the Hardy-Weinberg equilibrium model (Klug and Cummings 2000).
The stratification of CYP2E1 phenotype parameters per genotype showed the following values: mRNA content c1/c1: GM = 1.0645; range = 2.069-0.304; cl/c2, GM = 1.056, range = 2.123-0.477; c2/c2, GM = 1.319, range = 1.708-1.153. The CHZ metabolic ratios for each genotype were as follows: c1/c1, GM = 0.327, range = 2.362-0.0023; c1/c2, GM = 0.367, range = 1.597-0.0310; c2/c2, GM = 0.430, range = 2.287-0.117. There was no apparent influence of genotype on the measured mRNA content levels and CHZ metabolic ratios.
Relationships between toluene exposure and CYP2E1 phenotype. We found a correlation between the toluene exposure ratio and CYP2E1 mRNA content ([r.sup.2] = 0.0854, [beta] = 0.0929, p = 0.016; n = 67) (Figure 4). However, the CHZ metabolic ratio did not correlate with either the toluene exposure ratio ([r.sup.2] = 0.237, [beta] = -0.007, p = 0.744; n = 84) or CYP2E1 mRNA content ([r.sup.2] = 0.215, [beta] = -0.026, p = 0.686; n = 78) (Table 3).
Obesity, age, and smoking, as well as consumption of alcohol and certain drugs, have been shown to modulate CYP2E1 expression (Bebia et al. 2004; Benowitz et al. 2003; Frye and Branch 2002; Lieber 2004; Park et al. 1993; Simi and Ingelman-Sundberg 1999). Additionally, the use of personal protective equipment can reduce exposure to toluene and other VOCs. To address their potential confounding effect on CYP2E1 expression by toluene occupational exposure, we performed a linear regression analysis (simple and multiple) by adjusting for the variables mentioned above. None of them had any appreciable effect on the relationship between the toluene exposure ratio and mRNA content (Table 4).
Relation between toluene exposure ratio and CYP2E1 mRNA content stratified by genotype. The relationship between toluene exposure ratio and CYP2E1 mRNA content was stratified according to RsaI/PstI polymorphisms, but this association was not modified by genotype in a slope analysis.
We investigated the effects of toluene exposure on expression of the CYP2E1 phenotype by measuring CYP2E1 mRNA induction in peripheral lymphocytes and CHZ metabolism in workers exposed to organic solvents and then determining whether these mRNA content and CHZ metabolic data were associated with genotype.
Toluene in the work environment. Toluene exposure in the present group of subjects (GM = 52.80 ppm) was to similar to the lower limit reported for toluene exposure in a previous study of workers from 25 Mexican companies (52.5-931 ppm) in which the workers routinely handled organic solvents, paints, and varnishes (Madrigal-Bujaidar et al. 1996). Regrettably, both studies revealed environmental toluene concentrations that exceeded the limits set by Mexican regulations (NOM-010-STPS-1999 2000). Indeed in the present study, 54% of our study population was above the toluene MPEL. Therefore, stricter regulations should be implemented to ensure safe conditions in the occupational environment.
Hippuric acid content in urine. Hippuric acid has been used extensively as a toluene exposure biomarker, but this metabolite may occur in the diet, that is, via some fruits and food preservatives (Kawamoto et al. 1996). In this study, a statistically significant increase in hippuric acid concentrations during the work shift (48%) demonstrated active absorption and biotransformation of toluene by exposed workers. Despite the high toluene levels in air, the hippuric acid concentrations remained below the MBPL. This apparent inconsistency between the environmental and the biologic data leads to a disagreement between the MPEL and MBPL. Thus, an environmental exposure to toluene of 50 ppm for an 8 hr work shift resulted in a urinary hippuric acid concentration of < 2.5 g/g creatinine. De Bruin (1980) studied a group of volunteers exposed to 100 ppm toluene for 8 hr (twice the MPEL), but this high level of exposure produced a relatively low urinary hippuric acid excretion of 1.2 g/g creatinine. Although toluene is one of the main constituents of the organic solvent used in the print industry, these mixtures also contain many other VOCs that may be potential CYP2E1 substrates that may competitively inhibit its activity, as has been described for other chemicals (Campo et al. 1998; Tardif et al. 1993; Uaki et al. 1995).
Toluene effects on CYP2EI phenotype. Various factors, including exposure to certain xenobiotics, can induce CYP2E1 expression and thereby result in an increase in its metabolic activity. Such induction could be a risk to the health of persons exposed to CYP2E1 protoxicant substrates; thus, CYP2E1 expression demands close monitoring in those individuals.
The CHZ metabolic ratio. Most of our subjects showed small CHZ metabolic ratios (40% had ratios < 0.3), indicating a very low CHZ biotransformation rate, a finding that may be attributable to competitive inhibition of CHZ metabolism by VOCs. We did not detect significant differences between the toluene exposure ratio and CHZ metabolic ratio, or between CHZ metabolism and mRNA content. Lucas et al. (1999) reported a decreased CHZ metabolic ratio in shoemakers exposed to glue and suggested that there may be metabolic competition between CHZ and the organic chemicals present in the solvent's emissions. Furthermore, Ernstgard et al. (1999) found evidence that coexposure to acetone and CHZ or to toluene and CHZ increased plasma concentrations of both the organic chemicals and CHZ in human males, indicating that there was metabolic competition as a result of these interactions. In addition, Powell et al. (1998) found that human livers showed no correlation between mRNA levels and CYP2E1 protein content and p-nitrophenol and CHZ hydroxylation activity. Likewise, Sumida et al. (1999) reported no correlation between CYP2E1 mRNA level and CHZ hydroxylation in human liver biopsies. Thus, these lack of associations suggests that the CHZ metabolic ratio may not be an appropriate biomarker for toluene exposure when evaluated directly at the occupational site.
CYP2E1 mRNA induction. The associations of peripheral lymphocyte CYP2E1 mRNA content with environmental toluene or urinary hippuric acid were statistically significant. Furthermore, the peripheral lymphocyte CYP2E1 mRNA with the toluene metabolic ratio, a parameter that considers both exposure and disposition, was also significant.
The observed correlation between CYP2E1 mRNA induction and the toluene metabolic ratio suggests that CYP2E1 mRNA content is a much more sensitive probe than is the CHZ metabolic ratio. Moreover, CYP2E1 mRNA content is a safe, noninvasive test, for which samples can be obtained on site, and its expression in human peripheral lymphocytes appears to be regulated by the same factors as those affecting the liver (Raucy etal. 1997).
The CYP2E1 response we observed in this study demonstrated that toluene exposure affects CYP2E1 mRNA content, but more studies on toluene toxicity are needed to fully characterize the mechanism of induction. Other chemicals, such as ethanol, can regulate CYP2E1 activity by altering protein stabilization without affecting transcriptional activity (Roberts etal. 1995). Ethanol has also been shown to increase CYP2E1 gene expression at high doses (> 300 mg/dL blood) (Badger etal. 1993). Finally, CYP2E1 genotype stratification did not modify the association between toluene exposure and mRNA content in peripheral lymphocytes.
In conclusion, our results suggest that CYP2E1 mRNA content may be a useful biomarker of physiologic effects in humans exposed to toluene. The mRNA response is the first step after its modulation and may not be affected by other factors that modify CYP2E1 enzyme activity, as has been suggested to be a complicating factor for CHZ metabolism. However, further studies are needed to fully characterize and validate the use of CYP2E1 mRNA content for health surveillance purposes.
Values for the correlation between the toluene exposure ratio and CYP2E1 mRNA content were incorrect in the manuscript published online. They have been corrected here.
Received 11 April 2005; accepted 12 October 2005.
Apostoli P, Brugnone F, Perbellini L, Cocheo V, Bellumo ML, Silvestri R. 1982. Biomonitoring of occupational toluene exposure. Int Arch Occup Environ Health 50:153-168.
ATSDR. 2000. Toxicological Profile for Toluene. Atlanta, GA: Agency for Toxic Substances and Disease Registry.
Badger TM, Huang J, Ronis M, Lumpkin CK. 1993. Induction of cytochrome P450 2E1 during chronic ethanol exposure occurs via transcription of the CYP2E1 gene when blood alcohol concentrations are high. Biochem Biophys Res Commun 190:780-785.
Bartels H, Bohmer M, Heierli C. 1972. Serum creatinine determination without protein precipitation. Clin Chem Acta 37:193-197.
Bebia Z, Buch SC, Wilson JW, Frye RF, Romkes M, Cecchetti A, et al. 2004. Bioequivalence revisited: influence of age and sex on CYP enzymes. Clin Pharmacol 76:618-627.
Benowitz NL, Peng M, Jacob P III. 2003. Effects of cigarette smoking and carbon monoxide on chlorzoxazone and caffeine metabolism. Clin Pharmacol Ther 74:468-474.
Bergmeyer HU, Horder M. 1980. International Federation of Clinical Chemistry, Scientific Committee. Expert panel on enzymes. IFCC document stage 2, draft 1; 1979-11-19 with a view to an IFCC recommendation. IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase. J Clin Chem Clin Biochem 18:521-534.
Boyum A. 1968. Separation of leucocytes from blood and bone marrow. Introduction. Scand J Clin Lab invest Suppl 97:7.
Brown K. 1995. Physical Status: The Use and Interpretation of Anthropometry. WHO Technical Report Series 854. Geneva: World Health Organization.
Byrne A, Kirby B, Sibin T, Ensminger S. 1991. Psychiatric and neurological effects of chronic solvent abuse. Can J Psychiatry 36:735-738.
Campo P, Lataye R, Cossec B, Villete V, Roure M, Barthelemy C. 1998. Combined effects of simultaneous exposure to toluene and ethanol on auditory function in rats. Neurotoxicol Teratol 20:321-332.
Cocheo V. 1983. Sampling of solvents on active charcoal: chemical and thermal recovery. G Ital Med Lav 5:153-158.
De Bruin A. 1980. Biochemical Toxicology of Environmental Agents. 2nd ed. Amsterdam: Elsevier, 426-434.
Ernstgard L, Gullstrand E, Johanson G, Lof A. 1999. Toxicokinetic interactions between orally ingested chlorzoxazone and inhaled acetone or toluene in male volunteers. Toxicol Sci 48:189-196.
Frye RF, Branch RA. 2002. Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects. Br J Clin Pharmacol 53:155-62.
Gonzalez-Jasso E, Lopez T, Lucas D, Berthou F, Manno M, Ortega A, et al. 2003. CYP2E1 regulation by benzene and other small organic chemicals in rat liver and peripheral lymphocytes. Toxicol Lett 144:55-67.
Guengerich FP, Shimada T. 1991. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol 4:391-407.
Hayashi SI, Watanabe J, Kawajiri K. 1991. Genetic polymorphism in the 5'-flanking region change the transcriptional regulation of the human cytochrome P45011E1 gene. J Biochem (Tokyo) 110:559-505.
Kawamoto T, Koga M, Oyama T, Kodama Y. 1996. Habitual and genetic factors that affect urinary background levels of biomarkers for organic solvent exposure. Arch Environ Contam Toxicol 30:114-120.
Klug WS, Cummings MR. 2000. Concepts of Genetics. 6th ed. Upper Saddle River, NJ: Prentice Hall.
Lieber CS. 1997. Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev 77:517-544.
Lieber CS. 2004. The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. Drug Metab Rev 36:511-529.
Lucas D, Berthou F, Girre C, Poitrenaud F, Menez JF. 1993. High-performance liquid chromatographic determination of chlorzoxazone and 6-hydroxychlorzoxazone in serum: a tool for indirect evaluation of cytochrome P4502E1 activity in humans. J Chromatogr 622:79-86.
Lucas D, Ferrara R, Gonzales E, Albores A, Manno M, Berthou F. 2001. Cytochrome CYP2E1 phenotyping and genotyping in the evaluation of health risks from exposure to polluted environments. Toxicol Lett 124:71-81.
Lucas D, Ferrara R, Gonzalez E, Bodenez P, Albores A, Manno M, et al. 1999. Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans. Pharmacogenetics 9:377-388.
Madrigal-Bujaidar E, Pina A, Hernandez I. 1996. Exposicion ocupacional a disolventes organicos. Rev Mex Patol Clin 43:15-20.
Mendoza-Cantu A, Castorena-Torres F, Bermudez M, Martinez-Hernandez R, Ortega A, Salinas JE, et al 2003. Genotype and allele frequencies of polymorphic cytochromes P450 CYP1A2 and CYP2E1 in Mexicans. Cell Biochem Funct 22:29-34.
Mercado-Calderon F. 1997. Contaminantes organicos volatiles. In: Introduccion a la Toxicologia Ambiental (Albert L, ed). Mexico City: Centro Panamericano de Ecologia Humana y Salud, Division de Salud y Ambiente, Organizacion Panamericana de la Salud, y Organizacion Mundial de la Salud, 299-313.
Mutti A. 1999. Biological monitoring in occupational and environmental toxicology. Toxicol Lett 108:77-89.
Nakajima T, Wang RS. 1994. Induction of cytochrome P450 by toluene. Int J Biochem 26:1333-1340.
NIOSH (National Institute of Occupational Safety and Health). 1994. Hippuric and Methyl Hippuric Acids in Urine. In: Manual of Analytical Methods. 4th ed. Available: http://www.cdn. gov/niosh/nmam/pdfs/8301.pdf [accessed 27 January 2006].
NOM-047-SSA1-1993. 1996. Norma Oficial Mexicana que Establece los Limites Biologicos Maximos Permisibles de Disolventes Organicos en el Personal Ocupacionalmente Expuestos (Mexican Official Regulation). Diario Oficial de la Federacion, 19 September and 23 September. DXVI 13:32-37 and 15:101-106.
NOM-010-STPS-1999. 2000. Norma Oficial Mexicana que Establece las Condiciones de Seguridad e Higiene en los Centros de Trabajo donde se Manejen, Transporten, Procesen o Almacenen Sustancias Quimicas Capaces de Generar Contaminacion en el Medio Ambiente Laboral (Mexican Official Regulation). Diario Oficial de la Federacion, 13 March. DLVIII 9, 2nd Section:l-128, 3rd Section:l-128 and 4th Section:l-128.
Park KS, Sohn DH, Veech RL, Song BJ. 1993. Translational activation of ethanol-inducible cytochrome P450 (CYP2E1) by isoniazid. Eur J Pharmacol 248:7-14.
Plee-Gautier E, Foresto F, Ferrara R, Bodenez P, Simon B, Manno M, et al. 2001. Genetic repeat polymorphism in the regulating region of CYP2E1: frequency and relationship with enzymatic activity in alcoholics. Alcohol Clin Exp Res 25:800-804.
Powell H, Kitteringham NR, Pirmohamed M, Smith, DA, Park BK. 1998. Expression of cytochrome P4502E1 in human liver: assessment by mRNA, genotype and phenotype. Pharmacogenetics 8:411-421.
Raucy JL, Schultz ED, Wester MR, Arora S, Johnston BE, Omdahl JL, et al. 1997. Human lymphocytes cytochrome P450 2E1, a putative marker for alcohol-mediated changes in hepatic chlorzoxazone activity. Drug Metabol Disp 25:1429-1435.
Roberts B J, Song B J, Soh Y, Park SS, Shoaf SE. 1995. Ethanol induces CYP2E1 by protein stabilization. Role of ubiquitin conjugation in the rapid degradation of CYP2E1. J Biol Chem 270:29632-29635.
Shayiq RM, Roberts DW, Rothstein K, Snawder JE, Benson W, Ma X, et al. 1999. Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen-induced lethality in mice: an explanation for high acetaminophen dosage in humans without hepatic injury. Hepatology 29:451-463.
Simi A, Ingelman-Sundberg M. 1999. Post-translational inhibition of cytochrome P-450 2E1 expression by chlomethiazole in Fao hepatoma cells. J Pharmacol Exp Thor 289:847-852.
Sumida A, Kinoshita K, Fukuda T, Matsuda H, Yamamoto I, Inaba T, et al. 1999. Relationship between mRNA levels quantified by reverse transcription-competitive PCR and metabolic activity of CYP3A4 and CYP2EI in human liver. Biochem Biophys Res Commun 262:499-503.
Tanaka E, Kurata N, Yasuhara H. 2003. How useful is the "cocktail approach" for evaluating human hepatic drug metabolizing capacity using cytochrome P450 phenotyping probes in vivo? J Clin Pharm Ther 28:157-165.
Tardif R, Lapare S, Krishnan K, Brodeur J. 1993. Physiologically based modeling of the toxicokinetic interaction between toluene and m-xylene in the rat. Toxicol Appl Pharmacol 120:266-273.
Uaki H, Kawai T, Mizunuma K, Moon CS, Zhang ZW, Inui S, et al. 1995. Dose-dependent suppression of toluene metabolism by isopropyl alcohol and methyl ethyl ketone after experimental exposure of rats. Toxicol Lett 81:229-234.
Wallen M. 1986. Toxicokinetics of toluene in occupationally exposed volunteers. Scand J Work Environ Health 12:588-593.
Wormhoudt LW, Commandeur JN, Vermeulen NP. 1999. Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity. Crit Rev Toxinol 29:59-124.
Ania Mendoza-Cantu, (1) Fabiola Castorena-Torres, (1) Mario Bermudez de Leon, (2) Bulmaro Cisneros, (2) Lizbeth Lopez-Carrillo, (3) Aurora E. Rojas-Garcia, (1) Alberto Aguilar-Salinas, (4) Maurizio Manno, (5) and Arnulfo Albores (1)
(1) Seccion de Toxicologia and (2) Departamento de Genetica y Biologia Molecular, Centro de Investigacion y de Estudios Avanzados, National Polytechnical Institute, Mexico City, Mexico; (3) Centro de Investigacion en Salud Poblacional, Instituto Nacional de Salud Publica, Cuernavaca, Morelos, Mexico; (4) Coordinacion Nacional de Salud en el Trabajo, Centro Medico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico; (5) Dipartimento di Scienze Mediche Preventive, Sezione di Tossicologia Occupazionale, Universita degli Studi di Napoli "Federico II," Naples, Italy
Address correspondence to A. Albores, Seccion de Toxicologia, Cinvestav-IPN, Ave. IPN 2508, Col. Zacatenco, CP 07360, Mexico City, Mexico. Telephone: 52-55-5061-3308. Fax: 52-55-5061-3395. E-mail: email@example.com
We thank L.M. Del Razo and L. Sarkissian for critical review and R.A. Reyes Mejia and M.L. Lopez Gonzalez for analytical work.
This investigation was supported by CONACYT Mexico (project M0061-M9602), which also provided a grant to A.M.-C. (95754), and the Mexico-Italy Cooperation Program 2003-2005 (project 27).
The authors declare they have no competing financial interests.
Table 1. Anthropometric characteristics and habits of the study population. Variable Frequency or value No. 97 Age (years) (a) 34.2 [+ or -] 9.8 (18-63) Years employed (a) 3.5 [+ or -] 1.6 (1-9) BMI (kg/[m.sup.2]) (a) 26.98 [+ or -] 4.15 (20.38-40.03) Smoking status (%) (b) Nonsmoker 42 (43) Smoker 55 (57) Drinking status (%) Never 8 (8) Seldom 79 (82) Frequent 9 (10) (a) Expressed as mean [+ or -] SD (range). (b) Expressed as number of individuals (percentage of population). Table 2. Environmental and biologic parameters in toluene-exposed subjects from the print industry. Variable No. GM (range) Environmental toluene (ppm) 94 52.80 (10-760) Urinary hippuric acid (g/g creatinine) 90 Beginning of the shift 0.027 (ND-0.167) End of the shift 0.041 * (ND-0.177) Toluene exposure ratio (a) 84 0.122 (0.007-3.366) CHZ metabolic ratio (b) 93 0.33 (0-9.3) CYP2E1 mRNA content (c) 79 1.07 (0.30-3.08) ND, not detected. (a) Toluene exposure ratio (individual environmental toluene concentration/hippuric acid concentration quotient). (b) CHZ metabolic ratio (60H-CHZ/CHZ quotient). (c) Expressed as average value. * Statistically significant difference from concentrations at the beginning of the work shift (p < 0.05). Table 3. Multiple regression analysis modeling the effects of toluene exposure on CYP2E1 phenotype and of CYP2E1 mRNA content on CHZ metabolic ratio. mRNA content Variable [beta] [r.sup.2] 95% CI n Toluene exposure ratio 0.099 0.202 0.020 to 0.177 67 mRNA content CHZ metabolic ratio Variable [beta] [r.sup.2] 95% CI n Toluene exposure ratio -0.007 0.237 -0.055 to 0.040 84 mRNA content -0.026 0.215 -0.159 to 0.105 78 CI, confidence interval. Models were adjusted for alcohol and drug consumption, smoking habit, BMI, use of personal protection equipment, and age. Table 4. Effects of potential confounders on CYP2E1 mRNA content. Variable [beta] [r.sup.2] 95% CI Alcohol consumption -0.034 0.0267 -0.081 to 0.012 Recent alcohol consumption -0.025 0.0085 -0.086 to 0.036 Smoking habit -0.125 0.0295 -0.289 to 0.037 Current drug consumption -0.003 0.0002 -0.063 to 0.056 BMI 0.128 0.0451 -0.005 to 0.263 Use of protection equipment 0.024 0.0175 -0.017 to 0.065 Age 0.000 0.0003 -0.009 to 0.010 CI, confidence interval of multiple regression analysis.
|Printer friendly Cite/link Email Feedback|
|Publication:||Environmental Health Perspectives|
|Date:||Apr 1, 2006|
|Previous Article:||Monensin improves the effectiveness of meso-dimercaptosuccinate when used to treat lead intoxication in rats.|
|Next Article:||Antiestrogens inhibit xenoestrogen-induced brain aromatase activity but do not prevent xenoestrogen-induced feminization in Japanese medaka (Oryzias...|